Literature DB >> 11498210

Pricing and reimbursement of pharmaceuticals in the Baltic States.

N Freemantle1, D Behmane, K de Joncheere.   

Abstract

Mesh：

Year:  2001        PMID： 11498210     DOI： 10.1016/S0140-6736(01)05496-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Medicalisation, limits to medicine, or never enough money to go around?

Authors:  Nick Freemantle; Suzanne Hill
Journal:  BMJ       Date:  2002-04-13

2.  Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country.

Authors:  Dragan R Milovanovic; Radomir Pavlovic; Miroslav Folic; Slobodan M Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2004-04-01       Impact factor: 2.953

3.  Supply and regulation of medicines.

Authors:  T Walley; E A Mossialos; M Mrazek; C P de Joncheere
Journal:  BMJ       Date:  2005-07-23

Review 4.  Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States.

Authors:  Sabine Vogler; Claudia Habl; Martina Bogut; Luka Voncina
Journal:  Croat Med J       Date:  2011-04-15       Impact factor: 1.351

5.  Critical Appraisal of Reimbursement List in Bosnia and Herzegovina.

Authors:  Sabina Mujkic; Valentina Marinkovic
Journal:  Front Pharmacol       Date:  2017-03-17       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.